Analysed CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) News Sources
Why Sarepta Therapeutics (SRPT) Is Down 11.2% After CEO Retirement Plan And Japan Gene Therapy Launch - And What's Next
01-03-2026
yahoo.com
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
26-03-2026
yahoo.com
Is Chugai Pharmaceutical (TSE:4519) Still Attractively Priced After Its Strong Multi Year Run
13-04-2026
yahoo.com
Sarepta Stock Slumps. Why an Earnings Beat Wasn’t Enough for the S&P 500 Loser.
07-05-2026
yahoo.com
What is the current price of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The current price of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is $23.37.
CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) since the previous trading day is $-0.4.
CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) since the previous trading day is -1.6828%.
What is the most recent average sentiment score for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The most recent average sentiment score for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is 40 out of 100.
What is the most recent average sentiment for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The most recent sentiment for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is .
SEC-8K** Filing Available For CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.